Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease c syndrome
Phenotype C0018801|heart failure
Sentences 21
PubMedID- 23508725 The prognostic implication of metabolic syndrome in patients with heart failure.
PubMedID- 24265747 We sought to elucidate the relationship between nt-probnp and components of metabolic syndrome in patients with congestive heart failure (chf).
PubMedID- 26417279 We investigated the impact of obesity on cardiac prognosis in chronic heart failure (chf) patients, with or without metabolic syndrome.
PubMedID- 24403266 Of the nine treatment-related events, one was reported by the investigator as tigatuzumab related (peripheral edema) and the other eight were considered by investigators as possibly related to gemcitabine (pleural effusion, urinary tract infection, pneumonia, anemia [two patients], hemolytic uremic syndrome with bowel perforation, heart failure, and vomiting).
PubMedID- 25464226 Prognostic impact of metabolic syndrome in patients with chronic heart failure: data from gissi-hf trial.
PubMedID- 23134910 The study concluded that metabolic syndrome is significantly associated with heart failure.
PubMedID- 22962535 In our study, we compared plasma fatty acid compositions among heart failure patients with and without metabolic syndrome.
PubMedID- 22073325 Hypertensive heart failure associated with middle aortic syndrome reversed dramatically by endovascular management.
PubMedID- 26242711 The role of metabolic syndrome in heart failure.
PubMedID- 26214747 Acute heart failure in patients with acute aortic syndrome: pathophysiology and clinical-prognostic implications.
PubMedID- 26576280 Iron overload-related heart failure in a patient with transfusion-dependent myelodysplastic syndrome reversed by intensive combined chelation therapy.
PubMedID- 24855642 Hyperinsulinemia contributes to cardiac hypertrophy and heart failure in patients with the metabolic syndrome and type 2 diabetes.
PubMedID- 21420060 Chronic heart failure is one of the most important geriatric syndromes, associated with disability, increased hospital admissions, and high mortality.
PubMedID- 23882059 A recently described positive association of plasma acylated ghrelin with blood pressure and left ventricular mass may represent a compensatory mechanism to overcome the development of heart failure in patients with metabolic syndrome (60).
PubMedID- 20021625 Longitudinal and cross-sectional investigational studies since 1990 have associated ggt with an increase in all-cause mortality, as well as chronic heart disease events such as congestive heart failure and components of the metabolic syndrome (abnormal body mass index and levels of high-density lipoprotein cholesterol, glucose, triglycerides, and systolic and diastolic blood pressure).
PubMedID- 25364669 It is seen in congestive heart failure and cirrhosis of liver, nephrotic syndrome and chronic kidney disease.
PubMedID- 22187237 Plasma adiponectin concentration and its association with metabolic syndrome in patients with heart failure.
PubMedID- 23657904 High-fructose intake elevated blood pressure and glucose levels; moreover, high-fructose diet activated cardiac fas-dependent and mitochondria-dependent apoptotic pathways and suppressed the survival pathway, which might provide one possible mechanism for developing heart failure in patients with metabolic syndrome.
PubMedID- 23671959 Common causes of ascites are portal hypertension including cirrhosis of liver and congestive heart failure, hypoalbuminemia associated with nephrotic syndrome, intra-abdominal malignancy and abdominal tuberculosis.
PubMedID- 26557394 Acute systolic heart failure associated with complement-mediated hemolytic uremic syndrome.
PubMedID- 24804113 Hypereosinophilic syndrome leading to severe right-sided heart failure in a patient with ebstein's anomaly.

Page: 1